ETBI.US Eastgate Biotech Corp

Healthcare Biotechnology USA Stocks
0.0050 USD
Close of Oct 17, 2026
0.0001 0.0050
Market cap
USD 5.29M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2017.

Is ETBI.US undervalued?

Graham number

The Graham number of Eastgate Biotech Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Eastgate Biotech Corp fundamental analysis

No fundamental analysis for Eastgate Biotech Corp yet.

Eastgate Biotech Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Eastgate Biotech Corp

Eastgate Biotech Corp., produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. The company is developing pharmaceutical products, such as Lorazepam spray for acute seizures; and EGP-1214, intraoral (sublingual) insulin tablet for diabetes and metabolic syndrome. It is also developing natural healing medication and other products, including E-drops NANO, a plant essential oil for urinary and vaginal tract infections; Es…

Full company profile